Skip to content

Erythromycin or metoclopramide to promote post-pyloric placement of a self-advancing nasojejunal feeding tube in critically ill patients: a prospective, multi-center, randomized-controlled trial

Erythromycin or metoclopramide to promote post-pyloric placement of a self-advancing nasojejunal feeding tube in critically ill patients: a prospective, multi-center, randomized-controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008211
Enrollment
Unknown
Registered
2016-04-02
Start date
2016-10-01
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

self-propelled feeding tubes insertion

Interventions

Sponsors

Guangdong General hospital, Guangdong Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ? aged at least 18 years; ? admitted to ICU; ? requiring enteral nutrition support; ? gastric residual volume increased (single measurement > 150ml or cumulative volume in 12 hours > 500ml); ? informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1. Indications of percutaneous gastrostomy or jejunostomy; 2. esophageal varices or strictures, or previous major gastro-esophageal surgery; 3. activity of the upper digestive tract hemorrhage; 4. serious injury or stenosis of nasopharynx; 5. severe coagulation disorder; 6. malignant tumor, peptic ulcer of the stomach or intestinal mechanical obstruction; 7. pregnant; 8. contraindication of erythromycin and metoclopramide; 9. history of allergy to meglumine diatrizoate.

Design outcomes

Primary

MeasureTime frame
success rate of post-pyloric placement of spiral nasaljejunal tubes;

Secondary

MeasureTime frame
post-D1 placement of feeding tubes;post-D2 placement of feeding tubes;post-D3 placement of feeding tubes;proportion of proximal jejunum placement;tube migration distance;adverse events;Incidence of ICU acquired infection;Incidence of ICU acquired multiple drug resistant bacteria infection;length of ICU stay;duration of mechanical ventilation;ICU mortality rate;

Countries

China

Contacts

Public ContactChunbo Chen

Guangdong General Hospital, Guangdong Academy of Medical Sciences

gghicu@163.com+86 13922745788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026